TATX-20

N/A

Report date: 2024/01/02 15:41:55

Base Information

Drug NameTATX-20
Drug Alias NameTATX-20
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody
Mechanisms of ActionCarbonic anhydrase XII inhibitors
TargetsCarbonic anhydrase XII
Therapy Area/IndicationsSolid tumoursOvarian Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesTalem Therapeutics LLC
China Registration ClassN/A

Develop Information

Active CompaniesTalem Therapeutics LLC +[2] 
Inactive CompaniesN/A
Active IndicationsSolid tumoursOvarian Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A